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How	the	US	states	have	learned	from	each	other	to
create	more	comprehensive	medical	cannabis
policies.
Medical	cannabis	was	first	legalized	in	California	in	1996	–	since	then,	32	more	states
have	done	the	same,	and	11	have	made	the	drug	legal	for	recreational	use.	A.	Lee
Hannah	and	Daniel	J.	Mallinson	take	a	close	look	at	how	the	US	states	have	learned
from	each	other	on	how	to	regulate	cannabis	in	the	face	of	a	continuing	federal	ban.
They	write	that	the	states	have	moved	on	from	their	initially	vague	laws,	enacting
measures	which	exert	much	closer	control	over	the	production	and	distribution	of
cannabis.
When	California	became	the	first	state	to	pass	a	medical	cannabis	initiative	in	1996,	Democratic	Senator	Diane
Feinstein	argued	that	Proposition	215,	which	made	the	medicinal	use	of	the	drug	legal,	was	so	poorly	written	that
“you’ll	be	able	to	drive	a	truckload	of	marijuana	[sic]	through	the	holes	in	it.”	Her	depiction	of	California’s	law,	and
other	early	adopters’	laws,	is	not	wholly	inaccurate.	However,	medical	cannabis	policies	have	become	increasingly
complex	and	institutionalized,	as	we	describe	in	our	recent	work.
In	previous	posts,	we	discussed	how	cannabis	policies	were	adopted	by	the	US	states	–	especially	in	light	of	federal
prohibition.	We	also	addressed	the	challenge	of	rolling	back	state	cannabis	liberalization.	In	our	latest	work,	we	set
out	to	learn	about	what	has	been	passed.	We	find	that	state	cannabis	policies	and	regulations	have	become
increasingly	complex	over	time.	The	earliest	adopting	states	wrote	vague	laws	that	essentially	greenlit	cannabis	for
medical	use	–	providing	patients	an	affirmative	defense	from	state	cannabis	prosecution	and	allowing	them	the
opportunity	to	grow	or	purchase	a	personal	supply	of	cannabis	–	but	created	little	structure	beyond	that.	They	did	so
out	of	fear	from	federal	threats	of	prosecution	for	state	workers	engaged	in	implementing	cannabis	programs.	So,
states	simply	turned	a	blind	eye	to	use	for	medical	purposes.	Recent	laws,	however,	not	only	enable,	but	directly
regulate	and	legitimize	an	industry	that	remains	expressly	prohibited	by	federal	law.	It	is	one	thing	to	turn	a	blind
eye	to	the	violation	of	federal	law,	it	is	quite	another	to	build	up	an	intricate	infrastructure	to	support	it.	So,	what
happened?
States	operated	in	legally	perilous	territory	where	cannabis	was	concerned	during	the	Clinton	and	Bush
Administrations.	When	President	Obama’s	Department	of	Justice	(DOJ)	issued	the	Ogden	Memo,	stating	that
federal	prosecutors	“should	not	focus	federal	resources	in	your	states	on	individuals	whose	actions	are	in	clear	and
unambiguous	compliance	with	existing	state	laws	providing	for	the	medical	use	of	cannabis”	–	DOJ	inadvertently
encouraged	states	to	develop	more	robust	programs	to	remain	legally	compliant.	This	was	amplified	by	the	Cole
Memos	in	2011	and	2013	that	encouraged	well-regulated	state	cannabis	programs.	According	to	Cole,	“We	were
saying	to	the	states,	‘You	guys	have	to	become	serious	about	your	regulatory	enforcement	here.’	Recognizing	that
it	hadn’t	been	done	very	well	in	the	past,	we	were	basically	admonishing	them.”	Since	then,	states	have	been
learning	from	one	another,	both	in	terms	of	the	policy	details	and	the	politics	of	medical	cannabis.
Figure	1	–	Timeline	of	medical	and	recreational	cannabis	adoptions	
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NOTE:	Graphic	includes	the	number	of	states	that	have	adopted	comprehensive	medical	and	recreational	cannabis	policies	from
https://www.ncsl.org/research/health/state-marijuana-laws.aspx.	States	with	legal	cannabidiol	(CBD)	are	not	included.
Learning	about	policy	
States	have	converged	on	policy	solutions	by	developing	more	regulated	systems	that	centralize	the	harvesting,
processing,	and	supplying	of	cannabis.	These	developments	led	to	a	“medicalization”	process,	where	state
regulators	were	forced,	by	federal	cannabis	prohibition,	to	act	like	the	Food	and	Drug	Administration	in	regulating
the	industry.	These	changes	further	legitimized	the	use	of	cannabis	as	a	medicine.	States	now	exert	more	control
over	distribution	of	the	product,	including	developing	testing	and	product	safety	protocols	and	even	shaping
business	models	by	allowing	for	or	prohibiting	vertical	integration	of	cannabis	production	and	sale.	Further,	states
limit	or	restrict	home	growing,	both	as	a	sign	of	increasing	medicalization	and	to	appease	commercial	producers.
Further,	states	send	delegations	to	other	states	to	sample	products	and	observe	programs	in	other	states	firsthand
and	early	adopters	like	Colorado	export	their	expertise.
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Learning	about	politics	
Medical	cannabis	advocacy	organizations	have	nimbly	used	direct	democracy	and	framing	policies	in	certain	ways
to	accelerate	the	spread	of	medical	cannabis	laws.	Seven	of	the	first	eight	programs	were	passed	via	direct
initiative	and	recent	adoptions	in	conservative	states	have	been	facilitated	by	initiatives.	Initiatives	have	also	been
used	to	get	around	reluctant	legislators	concerned	about	the	stigma	of	cannabis,	often	lagging	behind	their	voters’
rapidly	shifting	attitudes.	As	the	policy	spread	to	more	conservative	states,	advocacy	organizations	increased	their
political	contributions	to	Republicans.	Advocacy	organizations	also	adapted	how	they	frame	the	benefits	of	medical
cannabis	around	the	most	sympathetic	groups.	In	early	adopting	states,	the	focus	was	more	on	HIV/AIDS	and
cancer	patients	(i.e.,	wasting	diseases),	as	well	as	those	with	glaucoma.	While	these	have	not	gone	away	as
beneficiary	populations,	advocates	increasingly	point	to	children	with	severe	epilepsy	and	veterans	with	PTSD,	as
well	as	those	impacted	by	the	opioid	epidemic,	as	beneficiaries.	These	groups	are	viewed	more	favorably	by
conservative	lawmakers.
Figure	2	–	Medical	and	recreational	cannabis	policies	by	state	
NOTE:	Map	includes	states	with	comprehensive	medical	and	recreational	cannabis	policies	from
https://www.ncsl.org/research/health/state-medical-cannabis-laws.aspx.	States	with	legal	cannabidiol	(CBD)	are	not	included.
Increasing	the	pressure	for	federal	action	and	recreational	cannabis	
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Early	studies	of	policy	innovation	argued	that	an	innovation	gains	legitimacy	as	it	spreads	and	becomes	“something
states	ought	to	have.”	While	many	lament	the	federal	government’s	inaction	on	cannabis	policy,	it	does	feel	like	we
have	reached	a	critical	mass.	Currently,	66	US	senators	represent	states	with	comprehensive	medical	cannabis
laws	at	various	stages	of	implementation,	and	22	of	those	US	senators	also	represent	states	with	recreational
cannabis	programs.	Political	and	policy	experience	with	medical	cannabis	has	helped	advocates	advance
recreational	cannabis	in	11	states,	though	the	political	dynamics	are	notably	different.	As	pressure	increases	from
changing	public	opinion,	as	well	as	the	host	of	practical	problems	arising	from	the	mismatch	of	federal	prohibition
and	state	legalization,	not	to	mention	calls	for	criminal	justice	reform	in	the	wake	of	George	Floyd’s	killing,	attention
continues	to	turn	to	the	federal	government	for	some	form	of	action.	With	questions	of	who	will	hold	control	of
Congress	and	the	White	House,	what	such	action	looks	like	is	unlikely	to	be	determined	until	after	the	2020
election.
This	article	is	based	on	the	paper,	“Policy	and	Political	Learning:	The	Development	of	Medical	Marijuana
Policies	in	the	States”	in	Publius:	The	Journal	of	Federalism.
Please	read	our	comments	policy	before	commenting.
Note:	This	article	gives	the	views	of	the	author,	and	not	the	position	of	USAPP	–	American	Politics	and	Policy,	nor
the	London	School	of	Economics.
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